Literature DB >> 10387011

Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.

L Dassonneville1, K Bonjean, M C De Pauw-Gillet, P Colson, C Houssier, J Quetin-Leclercq, L Angenot, C Bailly.   

Abstract

Cryptolepine, matadine, and serpentine are three indoloquinoline alkaloids isolated from the roots of African plants: Cryptolepis sanguinolenta, Strychnos gossweileri, and Rauwolfia serpentina, respectively. For a long time, these alkaloids have been used in African folk medicine in the form of plant extracts for the treatment of multiple diseases, in particular as antimalarial drugs. To date, the molecular basis for their diverse biological effects remains poorly understood. To elucidate their mechanism of action, we studied their interaction with DNA and their effects on topoisomerase II. The strength and mode of binding to DNA of the three alkaloids were investigated by spectroscopy. The alkaloids bind tightly to DNA and behave as typical intercalating agents. All three compounds stabilize the topoisomerase II-DNA covalent complex and stimulate the cutting of DNA by topoisomerase II. The poisoning effect is more pronounced with cryptolepine than with matadine and serpentine, but none of the drugs exhibit a preference for cutting at a specific base. Cryptolepine which binds 10-fold more tightly to DNA than the two related alkaloids proves to be much more cytotoxic toward B16 melanoma cells than matadine and serpentine. The cellular consequences of the inhibition of topoisomerase II by cryptolepine were investigated using the HL60 leukemia cell line. The flow cytometry analysis shows that the drug alters the cell cycle distribution, but no sign of drug-induced apoptosis was detected when evaluating the internucleosomal fragmentation of DNA in cells. Cryptolepine-treated cells probably die via necrosis rather than via apoptosis. The results provide evidence that DNA and topoisomerase II are the primary targets of cryptolepine, matadine, and serpentine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10387011     DOI: 10.1021/bi990094t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens.

Authors:  Tryphon K Mazu; Jagan R Etukala; Xue Y Zhu; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2010-11-05       Impact factor: 3.641

2.  Exploring new pharmacology and toxicological screening and safety evaluation of one widely used formulation of Nidrakar Bati from South Asia region.

Authors:  Afria Zaman; Md Shamsuddin Sultan Khan; Lucky Akter; Sharif Hossain Syeed; Jakia Akter; Abdullah Al Mamun; Md Ershad Alam; Md Ahsan Habib; Md Abdul Jalil
Journal:  BMC Complement Altern Med       Date:  2015-04-16       Impact factor: 3.659

3.  Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens.

Authors:  Comfort A Boateng; Xue Y Zhu; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Eur J Med Chem       Date:  2011-02-23       Impact factor: 6.514

4.  Differential regulation of fluorescent alkaloid metabolism between idioblast and lacticifer cells during leaf development in Catharanthus roseus seedlings.

Authors:  Mai Uzaki; Kotaro Yamamoto; Akio Murakami; Yushiro Fuji; Miwa Ohnishi; Kimitsune Ishizaki; Hidehiro Fukaki; Masami Yokota Hirai; Tetsuro Mimura
Journal:  J Plant Res       Date:  2022-03-04       Impact factor: 2.629

Review 5.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

6.  CoMFA studies and in vitro evaluation of some 3-substituted benzylthio quinolinium salts as anticryptococcal agents.

Authors:  Sidney Bolden; Comfort A Boateng; Xue Y Zhu; Jagan R Etukala; Suresh K Eyunni; Melissa R Jacob; Shabana I Khan; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2013-09-03       Impact factor: 3.641

7.  Recombinagenic effect of cryptolepine in uvsH+//uvsH+ and uvsH//uvsH diploid strains of Aspergillus nidulans.

Authors:  S J R Chiuchetta; M A A Castro-Prado
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

8.  Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells through Inhibition of Topoisomerase and Induction of DNA Damage.

Authors:  Harish C Pal; Santosh K Katiyar
Journal:  Molecules       Date:  2016-12-21       Impact factor: 4.411

9.  Synthesis and Evaluation of the Tetracyclic Ring-System of Isocryptolepine and Regioiso-Mers for Antimalarial, Antiproliferative and Antimicrobial Activities.

Authors:  Katja S Håheim; Emil Lindbäck; Kah Ni Tan; Marte Albrigtsen; Ida T Urdal Helgeland; Clémence Lauga; Théodora Matringe; Emily K Kennedy; Jeanette H Andersen; Vicky M Avery; Magne O Sydnes
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

10.  Structural investigation of heteroyohimbine alkaloid synthesis reveals active site elements that control stereoselectivity.

Authors:  Anna Stavrinides; Evangelos C Tatsis; Lorenzo Caputi; Emilien Foureau; Clare E M Stevenson; David M Lawson; Vincent Courdavault; Sarah E O'Connor
Journal:  Nat Commun       Date:  2016-07-15       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.